Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors(Stage IA-IB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04449874
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerAdvanced Solid Tumors
Genentech, Inc. 498
Early research (Phase 1)Ended earlyNCT01233505
What this trial is testing

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Active Not RecruitingNCT05581004
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNSCLCHNSCC+9 more
Genentech, Inc. 165
Early research (Phase 1)Not Yet RecruitingNCT07593144
What this trial is testing

A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)

Who this might be right for
Advanced Solid Tumors
Foresight Therapeutics (Hefei) Co., Ltd. 156
Early research (Phase 1)Looking for participantsNCT07100249
What this trial is testing

HDM2012 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 129
Early research (Phase 1)Study completedNCT03475251
What this trial is testing

CS1003 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
CStone Pharmaceuticals 108
Early research (Phase 1)UnknownNCT05164458
What this trial is testing

Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies

Who this might be right for
Advanced Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 320
Early research (Phase 1)Ended earlyNCT04303858
What this trial is testing

Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 189
Early research (Phase 1)Study completedNCT03809767
What this trial is testing

CS1003 in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
CStone Pharmaceuticals 107
Early research (Phase 1)Study completedNCT04261413
What this trial is testing

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. 16
Early research (Phase 1)Looking for participantsNCT06717750
What this trial is testing

CSCJC3456 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. 102
Early research (Phase 1)Looking for participantsNCT07004296
What this trial is testing

HDM2005 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Early research (Phase 1)Study completedNCT04250155
What this trial is testing

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Genentech, Inc. 195
Early research (Phase 1)UnknownNCT05300438
What this trial is testing

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Who this might be right for
Cancer (With or Without Metastasis)
Tyligand Bioscience (Shanghai) Limited 74
Early research (Phase 1)Looking for participantsNCT05645276
What this trial is testing

AK129 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors(Stage IA-IB)
Akeso 182
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Early research (Phase 1)Study completedNCT02965885
What this trial is testing

TAS-116 in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 31
Early research (Phase 1)Looking for participantsNCT06418061
What this trial is testing

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
UnresectableLocally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 198
Early research (Phase 1)Study completedNCT05767060
What this trial is testing

BAT7104 Injection in Patients With Advanced Malignant Tumors.

Who this might be right for
Advanced Malignant Tumor
Bio-Thera Solutions 86
Early research (Phase 1)Study completedNCT02794571
What this trial is testing

Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced/Metastatic Tumors
Genentech, Inc. 518
Next Page